EXOCHAIN

EXOCHAIN

Created using Figma
EXOCHAIN
The integrity of the established identity is evaluated and maintained by EXOCHAIN's Odentity (TM) framework that provides an indication for evaluating the entity's identity establishment. By enabling users to specify access permissions for accessing data, it is easy to programmatically release data to humans and machines. EXOCHAIN reduces the time and cost required to establish a cautious online interaction that keeps the legal position. When applied as the first use case to the world of clinical research and precision medical care, the LYNK protocol addresses data maintenance and transaction inefficiencies, facilitates democratic access to participation in clinical trials, and then precision Catalyzes the advancement of medical care.
Aug 1, 2018
Sep 30, 2018
100% completed
Raised funds - no Data
past
Token Details
Accepted Currencies
ETH
Company Details
Registered Country
United States
Additional Details
KYC
Yes
Categories
Platform

About EXOCHAIN

We describe a blockchain protocol that provides individuals, organizations and machines (“Entity(ies”)  the ability to form a strong, verified digital identity, and  mechanisms to control the seamless release of verified personal data to third parties. The LYNKTM protocol’s first application is intended to make it easier to share medical record data with healthcare professionals and medical research organizations. The integrity of one’s established identity is evaluated and maintained through EXOCHAIN’s OdentityTM framework, which provides metrics for scoring an Entity’s identity establishment. In conjunction with an interface that allows users to designate permissions for accessing their data, which facilitates the programmatic release of data to humans and machines, EXOCHAIN reduces the time and costs required to establish prudent online interactions that possess legal standing. The LYNK protocol, when applied to the world of clinical research and precision medicine as a first use case, addresses data maintenance and transactional inefficiencies, facilitates democratized access to clinical trial participation, and subsequently catalyzes advancements in precision medicine.

EXOCHAIN Roadmap

  • Q2 2017

  • Market Research.
    Technical Feasibility Assessment.
    Team Setup.
  • Q3 2017

  • Angel Investment.
    Establish Securely Guarded Facility.
    Hire Key Advisors and Contractors.
  • Q4 2017

  • Friends and Family.
    Discounted Presale.
    Establish Board of Directors.
    Close Exclusive Market Access.
    Contracts.
    Release Focused White Paper.
    Trademark Applications.
    SDLC Development.
    DEVOPS Environment Setup.
  • Q1 2018

  • Convert Contractors to Employees.
    Commence MVP Development.
    21CFR Part 11 Audit.
    BlueCloud featured on Fox Business.
    Network, 60M households (2/8 & 2/11).
    Token Pre-sale.
    Smart Contracts.
    Security Audit.
    Patent Applications.
    BlueCloud Mobile App Public Alpha.
  • Read More
  • Q2 2018

  • Public Beta.
    Testnet Integration.
    dApp Smart Contracts.
    dApp Servers.
    dApp Security Audits.
    Mainnet Integration.
    Third-party Login Verification.
    Identity Adjudication & Scoring.
    Contractually Legal Jurisdictional Standing.
  • Q3 2018

  • Token Public-sale.
    Wallet Management & Reporting.
    Know Your Customer Social.
    Graph Connectivity.
  • Q4 2018

  • Key Recovery, Escrow, and PACE Stewards.
    Mobile Transaction Alerting & Management.
    Seamless Release Authority.
    Personal Medical Record Custody.
  • 2019

  • Medical Network Query Analysis.
    Machine Learned Metadata.
    Enhancement.

EXOCHAIN Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Robert Stewart
Founder & CEO
unverified
David Mccurley
Chief Architect
unverified
Norm Archer
Chief Operating Officer
unverified
Ralph Seferian
Chief Revenue Officer
unverified
Trish Deeney
Senior Project Manager
unverified
Steve Cole
CFO
unverified
Mark Marcantano
GM, The Americas
unverified
Justice Rines
In-House Counsel
unverified
Alan Paquette
Director of Human Resources
unverified
Evan Pellett
Chief of Talent
unverified
Paul Christen
Sr. Architect
unverified
Konrad Rauscher
Engineer
unverified
Paisley Stewart
Designer
unverified
Anthony Buonomo
Engineer
unverified
Hannah Wiley
Administrative Assistant
unverified
Skip Freeman
Technical Account Manager
unverified
Karl Rauscher
Board Member
unverified
Greg Koski
Board Member
unverified
Geoffrey Dardia
Board Member
unverified
Al Pacino
Board Member
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Stuart Goldman
Advisor
unverified
Daniel Winschel
U.S. Army Co-Founder
unverified

EXOCHAIN Last News

  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.